JMJD6 promotes melanoma carcinogenesis through regulation of the alternative splicing of PAK1, a key MAPK signaling component
Abstract Background Melanoma, originated from melanocytes located on the basal membrane of the epithelial tissue, is the most aggressive form of skin cancer that accounts for 75% of skin cancer-related death. Although it is believed that BRAF mutation and the mitogen-activated protein kinase (MAPK)...
Main Authors: | Xujun Liu, Wenzhe Si, Xinhua Liu, Lin He, Jie Ren, Ziran Yang, Jianguo Yang, Wanjin Li, Shumeng Liu, Fei Pei, Xiaohan Yang, Luyang Sun |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2017-11-01
|
Series: | Molecular Cancer |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s12943-017-0744-2 |
Similar Items
-
Metabolic reprogramming of cancer cells by JMJD6-mediated pre-mRNA splicing associated with therapeutic response to splicing inhibitor
by: Carolyn M Jablonowski, et al.
Published: (2024-03-01) -
The Novel Protease Activities of JMJD5–JMJD6–JMJD7 and Arginine Methylation Activities of Arginine Methyltransferases Are Likely Coupled
by: Haolin Liu, et al.
Published: (2022-02-01) -
JMJD3 in the regulation of human diseases
by: Xiangxian Zhang, et al.
Published: (2019-11-01) -
Prognostic Significance of JMJD3 Expression in Pleural Mesotheliomas
by: Lauren Rask-Nielsen, et al.
Published: (2021-07-01) -
The JMJD Family Histone Demethylases in Crosstalk Between Inflammation and Cancer
by: Jia Yang, et al.
Published: (2022-04-01)